4.8 Article

Activation of NMDA receptors and the mechanism of inhibition by ifenprodil

Journal

NATURE
Volume 534, Issue 7605, Pages 63-+

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nature17679

Keywords

-

Funding

  1. National Institutes of Health [MH085926, GM105730]
  2. Stanley Institute of Cognitive Genomics
  3. Burroughs Wellcome Fund Collaborative Research Travel Grant
  4. Robertson Research Fund of Cold Spring Harbor Laboratory
  5. Japan Society for the Promotion of Science
  6. Visiting Scientist program of the Janelia Research Center

Ask authors/readers for more resources

The physiology of N-methyl-D-aspartate (NMDA) receptors is fundamental to brain development and function. NMDA receptors are ionotropic glutamate receptors that function as heterotetramers composed mainly of GluN1 and GluN2 subunits. Activation of NMDA receptors requires binding of neurotransmitter agonists to a ligand-binding domain (LBD) and structural rearrangement of an amino-terminal domain (ATD). Recent crystal structures of GluN1-GluN2B NMDA receptors bound to agonists and an allosteric inhibitor, ifenprodil, represent the allosterically inhibited state. However, how the ATD and LBD move to activate the NMDA receptor ion channel remains unclear. Here we applied X-ray crystallography, single-particle electron cryomicroscopy and electrophysiology to rat NMDA receptors to show that, in the absence of ifenprodil, the bi-lobed structure of GluN2 ATD adopts an open conformation accompanied by rearrangement of the GluN1-GluN2 ATD heterodimeric interface, altering subunit orientation in the ATD and LBD and forming an active receptor conformation that gates the ion channel.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available